Annual Total Long Term Liabilities
$68.35 M
-$8.59 M-11.17%
31 December 2023
Summary:
Trinity Biotech annual total long term liabilities is currently $68.35 million, with the most recent change of -$8.59 million (-11.17%) on 31 December 2023. During the last 3 years, it has fallen by -$37.21 million (-35.25%). TRIB annual total long term liabilities is now -47.28% below its all-time high of $129.65 million, reached on 31 December 2015.TRIB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$95.73 M
-$2.25 M-2.30%
30 September 2024
Summary:
Trinity Biotech quarterly total long term liabilities is currently $95.73 million, with the most recent change of -$2.25 million (-2.30%) on 30 September 2024. Over the past year, it has increased by +$27.39 million (+40.07%). TRIB quarterly long term liabilities is now -28.76% below its all-time high of $134.38 million, reached on 30 June 2015.TRIB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.2% | +40.1% |
3 y3 years | -35.3% | +401.4% |
5 y5 years | -24.1% | -11.7% |
TRIB Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -35.3% | +265.1% | -2.3% | +411.3% |
5 y | 5 years | -36.1% | +265.1% | -11.7% | +411.3% |
alltime | all time | -47.3% | >+9999.0% | -28.8% | >+9999.0% |
Trinity Biotech Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $95.73 M(-2.3%) |
June 2024 | - | $97.98 M(+8.5%) |
Mar 2024 | - | $90.34 M(+32.2%) |
Dec 2023 | $68.35 M(-11.2%) | $68.35 M(+0.0%) |
Sept 2023 | - | $68.35 M(-0.4%) |
June 2023 | - | $68.61 M(-15.9%) |
Mar 2023 | - | $81.63 M(+6.1%) |
Dec 2022 | $76.94 M(+310.9%) | $76.94 M(+0.5%) |
Sept 2022 | - | $76.53 M(-1.2%) |
June 2022 | - | $77.44 M(-19.7%) |
Mar 2022 | - | $96.44 M(+415.1%) |
Dec 2021 | $18.72 M(-82.3%) | $18.72 M(-1.9%) |
Sept 2021 | - | $19.09 M(-2.6%) |
June 2021 | - | $19.60 M(-81.2%) |
Mar 2021 | - | $104.46 M(-1.0%) |
Dec 2020 | $105.56 M(-1.3%) | $105.56 M(-0.3%) |
Sept 2020 | - | $105.91 M(-0.7%) |
June 2020 | - | $106.69 M(+0.4%) |
Mar 2020 | - | $106.30 M(-0.6%) |
Dec 2019 | $106.91 M(+18.8%) | $106.91 M(-1.4%) |
Sept 2019 | - | $108.42 M(+0.2%) |
June 2019 | - | $108.22 M(-0.4%) |
Mar 2019 | - | $108.66 M(+20.7%) |
Dec 2018 | $90.00 M(-15.5%) | $90.00 M(-4.6%) |
Sept 2018 | - | $94.38 M(-11.8%) |
June 2018 | - | $106.96 M(+0.2%) |
Mar 2018 | - | $106.75 M(+0.2%) |
Dec 2017 | $106.55 M(-7.8%) | $106.55 M(-7.1%) |
Sept 2017 | - | $114.74 M(+0.0%) |
June 2017 | - | $114.70 M(-0.0%) |
Mar 2017 | - | $114.71 M(-0.8%) |
Dec 2016 | $115.58 M(-10.8%) | $115.58 M(-10.6%) |
Sept 2016 | - | $129.25 M(+1.8%) |
June 2016 | - | $126.99 M(-0.2%) |
Mar 2016 | - | $127.27 M(-1.8%) |
Dec 2015 | $129.65 M(+444.5%) | $129.65 M(+4.0%) |
Sept 2015 | - | $124.66 M(-7.2%) |
June 2015 | - | $134.38 M(+440.1%) |
Mar 2015 | - | $24.88 M(+4.5%) |
Dec 2014 | $23.81 M(+5.8%) | $23.81 M(-9.9%) |
Sept 2014 | - | $26.44 M(+5.2%) |
June 2014 | - | $25.12 M(+8.5%) |
Mar 2014 | - | $23.15 M(+2.9%) |
Dec 2013 | $22.50 M(+49.4%) | $22.50 M(-9.2%) |
Sept 2013 | - | $24.77 M(+76.9%) |
June 2013 | - | $14.00 M(-3.5%) |
Mar 2013 | - | $14.51 M(-3.7%) |
Dec 2012 | $15.06 M(+120.3%) | $15.06 M(+37.6%) |
Sept 2012 | - | $10.94 M(+2.0%) |
June 2012 | - | $10.72 M(+1.5%) |
Mar 2012 | - | $10.56 M(+54.5%) |
Dec 2011 | $6.84 M(-6.7%) | $6.84 M(-15.7%) |
Sept 2011 | - | $8.12 M(+4.1%) |
June 2011 | - | $7.79 M(+6.9%) |
Mar 2011 | - | $7.29 M(-0.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $7.33 M(-73.3%) | $7.33 M(-4.0%) |
Sept 2010 | - | $7.64 M(+2.2%) |
June 2010 | - | $7.48 M(-69.6%) |
Mar 2010 | - | $24.61 M(-10.5%) |
Dec 2009 | $27.50 M(-1.4%) | $27.50 M(+19.7%) |
Sept 2009 | - | $22.98 M(-10.9%) |
June 2009 | - | $25.79 M(+4.5%) |
Mar 2009 | - | $24.69 M(-11.5%) |
Dec 2008 | $27.90 M(-21.7%) | $27.90 M(-16.2%) |
Sept 2008 | - | $33.29 M(-9.4%) |
June 2008 | - | $36.74 M(+16.4%) |
Mar 2008 | - | $31.58 M(-11.4%) |
Dec 2007 | $35.62 M(-22.4%) | $35.62 M(-8.8%) |
June 2007 | - | $39.05 M(-4.7%) |
Mar 2007 | - | $40.99 M(-10.7%) |
Dec 2006 | $45.93 M(+140.7%) | $45.93 M(+4.0%) |
Sept 2006 | - | $44.17 M(-8.2%) |
June 2006 | - | $48.13 M(+201.5%) |
Mar 2006 | - | $15.96 M(-16.3%) |
Dec 2005 | $19.08 M(+32.2%) | $19.08 M(+4.4%) |
Sept 2005 | - | $18.27 M(+45.8%) |
June 2005 | - | $12.54 M(-11.4%) |
Mar 2005 | - | $14.15 M(-1.9%) |
Dec 2004 | $14.43 M(-21.7%) | $14.43 M(-34.1%) |
Sept 2004 | - | $21.91 M(-7.9%) |
June 2004 | - | $23.79 M(+6.1%) |
Mar 2004 | - | $22.42 M(+21.7%) |
Dec 2003 | $18.43 M(+129.2%) | $18.43 M(-26.0%) |
Sept 2003 | - | $24.89 M(+407.0%) |
June 2003 | - | $4.91 M(-30.2%) |
Mar 2003 | - | $7.04 M(-12.5%) |
Dec 2002 | $8.04 M(+3.0%) | $8.04 M(+19.2%) |
Sept 2002 | - | $6.74 M(-0.3%) |
June 2002 | - | $6.76 M(-10.6%) |
Mar 2002 | - | $7.57 M(-3.0%) |
Dec 2001 | $7.80 M(+244.4%) | $7.80 M(+59.9%) |
Sept 2001 | - | $4.88 M(+2.2%) |
June 2001 | - | $4.78 M(+120.1%) |
Mar 2001 | - | $2.17 M(-4.3%) |
Dec 2000 | $2.27 M(-72.0%) | $2.27 M(-60.2%) |
Sept 2000 | - | $5.70 M(-11.1%) |
June 2000 | - | $6.41 M(-26.0%) |
Mar 2000 | - | $8.66 M(+7.1%) |
Dec 1999 | $8.09 M(-34.3%) | $8.09 M(-10.2%) |
Sept 1999 | - | $9.00 M(-12.6%) |
June 1999 | - | $10.30 M(-12.7%) |
Mar 1999 | - | $11.80 M(-4.2%) |
Dec 1998 | $12.31 M(+41.5%) | $12.31 M(-32.7%) |
Sept 1998 | - | $18.30 M(+94.7%) |
June 1998 | - | $9.40 M(+8.0%) |
Dec 1997 | $8.70 M(-3000.0%) | $8.70 M(-3000.0%) |
Dec 1996 | -$300.00 K(-400.0%) | -$300.00 K(-400.0%) |
Dec 1994 | $100.00 K(0.0%) | - |
Feb 1994 | - | $100.00 K |
Feb 1994 | $100.00 K | - |
FAQ
- What is Trinity Biotech annual total long term liabilities?
- What is the all time high annual total long term liabilities for Trinity Biotech?
- What is Trinity Biotech annual total long term liabilities year-on-year change?
- What is Trinity Biotech quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Trinity Biotech?
- What is Trinity Biotech quarterly long term liabilities year-on-year change?
What is Trinity Biotech annual total long term liabilities?
The current annual total long term liabilities of TRIB is $68.35 M
What is the all time high annual total long term liabilities for Trinity Biotech?
Trinity Biotech all-time high annual total long term liabilities is $129.65 M
What is Trinity Biotech annual total long term liabilities year-on-year change?
Over the past year, TRIB annual total long term liabilities has changed by -$8.59 M (-11.17%)
What is Trinity Biotech quarterly total long term liabilities?
The current quarterly long term liabilities of TRIB is $95.73 M
What is the all time high quarterly long term liabilities for Trinity Biotech?
Trinity Biotech all-time high quarterly total long term liabilities is $134.38 M
What is Trinity Biotech quarterly long term liabilities year-on-year change?
Over the past year, TRIB quarterly total long term liabilities has changed by +$27.39 M (+40.07%)